Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Emtricitabine

Open in the dashboard

Part D claims

2,385

Prescriptions dispensed, refills included

Drug cost

$758,482

Paid at the pharmacy, in all

Prescribers

160

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,385 claims for Emtricitabine from 160 prescribers, at a total drug cost of $758,482 paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 34 states and territories
Part D claims for Emtricitabine by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
FL 24 335 $109,005
NY 20 259 $78,900
CA 15 235 $59,649
TX 10 177 $58,581
GA 9 121 $39,269
MA 5 113 $55,064
CT 6 96 $26,562
WA 6 91 $18,374
VA 5 77 $29,780
IL 6 76 $25,038
PR 4 68 $22,834
NC 4 64 $16,990
OH 4 57 $12,391
LA 3 54 $14,185
TN 3 45 $13,700
The other 19 states and territories
State Prescribers Claims Drug cost
AZ 2 44 $24,205
NJ 3 38 $10,685
PA 3 37 $14,952
CO 2 36 $16,574
OR 3 36 $12,425
KY 1 36 $12,676
IN 3 35 $15,099
AR 2 32 $12,004
MD 2 28 $9,736
OK 2 27 $5,793
AL 2 27 $2,178
DC 2 26 $8,430
MS 2 25 $7,028
MN 2 24 $10,124
IA 1 15 $3,140
SC 1 14 $1,710
KS 1 14 $1,736
MO 1 12 $5,261
WI 1 11 $4,400

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 8 of 8
Part D claims for Emtricitabine by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Infectious Disease 64 1,015 $302,302
Internal Medicine 39 562 $204,543
Nurse Practitioner 25 355 $108,770
Family Practice 18 260 $88,063
Physician Assistant 6 87 $23,368
General Practice 6 79 $26,344
Hospitalist 1 14 $1,710
Preventive Medicine 1 13 $3,381

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
John Doweiko Internal Medicine MA 63 $37,325 None on record
Catherine Colquitt Infectious Disease TX 38 $10,164 None on record
Anita Fleenor-Ford Infectious Disease KY 36 $12,676 None on record
Marcia Senteno Infectious Disease CA 36 $11,385 None on record
David Weinrib Infectious Disease NC 30 $6,942 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for emtricitabine

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record